4 minute read
Jun. 18, 2022
Dorzagliatin: A Dual-Acting Full Glucokinase (GK) Activator for Diabetes
dorzagliatin
oral allosteric glucokinase activator Ph. III candidate in T2DM HbA1c reduction vs placebo Journal of Diabetes Research, Jan 14, 2017 Hua Medicine, Shanghai, CN
Reviewer:
Loading...
